ArticleInternational journal of women's health2026
Elevated Neutrophil Count as a Causal Risk Factor for Endometriosis: A Mendelian Randomization Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endometriosis is a chronic inflammatory gynecological disorder where immune dysregulation plays a central role in its pathogenesis. While previous observational studies have reported associations between circulating blood cell counts and endometriosis risk, it remains unclear whether these hematological alterations are a causal factor or merely a secondary consequence of the disease itself. This study used a bidirectional two-sample Mendelian randomization (MR) approach to investigate causal relationships between six circulating blood cell counts and endometriosis risk. Methods: We conducted bidirectional two-sample MR analyses using GWAS summary statistics from a meta-analysis of up to 563,946 individuals (blood cell traits) and the FinnGen R12 release (endometriosis: 18,349 cases, 208,924 controls). Genetic instruments included basophil, eosinophil, lymphocyte, monocyte, neutrophil, and total white blood cell counts. The inverse-variance weighted method served as the primary analysis, supported by MR-Egger, weighted median, Cochran's Q test, and leave-one-out analyses. Results: Forward MR analysis revealed that genetically predicted higher neutrophil count was causally associated with increased endometriosis risk (Odds Ratio [OR] = 1.113, 95% Confidence Interval [CI]: 1.038-1.194, P = 0.003). A similar significant causal effect was also found for total white blood cell count (OR = 1.096, 95% CI: 1.028-1.169, P = 0.005). Both associations remained significant after false discovery rate correction. No significant causal effects were observed for basophil, eosinophil, monocyte, or lymphocyte counts. The reverse MR analysis found no evidence of a causal effect of endometriosis liability on any blood cell trait. Conclusion: This study provides robust genetic evidence that an elevated neutrophil count is a causal risk factor for endometriosis, establishing systemic innate inflammation as a primary contributor to disease etiology rather than merely a secondary consequence. These findings highlight neutrophil-mediated inflammatory pathways as promising targets for novel therapeutic and preventive strategies in endometriosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.